BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Depomed sinks on dismal drug news]]>http://www.bloggingstocks.com/2009/10/12/depomed-sinks-on-dismal-drug-news/http://www.bloggingstocks.com/2009/10/12/depomed-sinks-on-dismal-drug-news/http://www.bloggingstocks.com/2009/10/12/depomed-sinks-on-dismal-drug-news/#commentsFiled under:

Depomed Inc. (NASDAQ: DEPO) opened Monday on a loss of nearly 50%, as traders panned the company's clinical trial results for Serada. The drug, which is intended to treat hot flashes related to menopause, met only one one of four co-primary goals in late-stage trials after 12 weeks.

Depomed was hoping to prove that Serada could help patients achieve a "statistically significant reduction in the frequency and severity of menopausal hot flashes." However, the company confessed that the placebo effect was unexpectedly high in clinical studies.

Continue reading Depomed sinks on dismal drug news

Depomed sinks on dismal drug news originally appeared on BloggingStocks on Mon, 12 Oct 2009 11:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Carl PelzelDEPODepomedFDAFood and Drug Administrationhot flash druginthenewsSeradatechnical analysisMon, 12 Oct 2009 11:30:00 EST